SGX Stocks :: Your One Stop SGX Stocks Info Blog

• Revenue: -38.2% (1Q10)
• Net Profit: -19.6% (1Q10)
• Outlook: The Group experienced slow down in the engineering business due to fewer projects available.
• With the global economic seeing signs of recovery, the Group expects better operating environment in the next two quarters.
• The Group believes that its advanced membrane technologies, particularly Membrane Bioreactor (MBR), have a competitive edge in industrial water and greater complexity wastewater treatment, for example petrochemical and chemical industries and industrial parks.
• The Group’s treatment revenue stream continues to improve and the Group will continue to improve its treatment business by building or acquiring more treatment plants, operating its own treatment plants and providing operation and maintenance services to its customers.

FINANCIAL RESULTS

FY 1Q 2Q 3Q 4Q Total
2010 8,845
2009 14,322 9,018 8,752 10,765 42,857
2008 9,581 12,353 13,984 15,291 51,209
2007 7,238 4,333 6,678 5,430 23,679
2006 4,597 7,244 6,500 5,482 23,823
-----------------------------------------------------------
Earnings (SGD '000)

FY 1Q 2Q 3Q 4Q Total
2010 1,098
2009 1,365 1,102 1,065 131 3,663
2008 2,106 3,126 2,149 1,074 8,455
2007 1,445 (2,347) (685) (1,624) (3,211)
2006 1,076 2,578 (445) 1,034 4,243
-----------------------------------------------------------
Dividends

FY Interim Final Special
2009 NA NA NA
2008 NA 0.03 NA
2007 NA NA NA
2006 NA 0.002 NA
-----------------------------------------------------------
Bonus / Rights / Stock Split

Date Type Details
NA
-----------------------------------------------------------
Share Data (SGD)

NAV = $0.2124
EPS = $0.0028 (3M FY10)
No of Shares = 397,596,000
-----------------------------------------------------------

ANALYSTS' TARGET PRICES

Broker Recommendation Target Price Date
NA